30 studies were found.

1.		No longer recruiting	506U78 in Treating Patients With Refractory Hematologic Cancer Conditions: recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
2.		No longer recruiting	Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease Conditions: stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; cardiac toxicity; stage I childhood Hodgkin's disease; ...
3.		No longer recruiting	Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia Conditions: B-cell childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
4.		No longer recruiting	Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy Condition: unspecified childhood solid tumor, protocol specific
5.		No longer recruiting	Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia Conditions: Burkitt's Lymphoma; B-cell childhood acute lymphocytic leukemia; stage IV childhood small noncleaved cell lymphoma; ...
6.		No longer recruiting	Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia Conditions: L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
7.		Completed	Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor Conditions: metastatic tumors of the Ewing's family; Neutropenia
8.		No longer recruiting	Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia Conditions: L3 adult acute lymphoblastic leukemia; stage IV adult diffuse small noncleaved cell/Burkitt's lymphoma; Burkitt's Lymphoma; ...
9.		No longer recruiting	Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Conditions: stage III childhood large cell lymphoma; stage IV childhood large cell lymphoma; childhood diffuse large cell lymphoma; ...
10.		No longer recruiting	Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors Conditions: childhood malignant testicular germ cell tumor; childhood mature and immature teratomas; Drug Toxicity; recurrent childhood malignant germ cell tumor; ...
11.		No longer recruiting	Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma Conditions: cardiac toxicity; localized osteosarcoma
12.		No longer recruiting	Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia Conditions: recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia
13.		No longer recruiting	Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma Condition: untreated childhood brain stem glioma
14.		Completed	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma Condition: untreated childhood brain stem glioma
15.		No longer recruiting	Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease Conditions: stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; stage IV childhood Hodgkin's disease; cardiac toxicity; ...
16.		No longer recruiting	Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma Conditions: nonmetastatic childhood soft tissue sarcoma; metastatic childhood soft tissue sarcoma
17.		Completed	Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer Conditions: childhood solid tumor; childhood acute lymphoblastic leukemia; psychosocial effects/treatment; childhood acute myeloid leukemia
18.		Completed	Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer Conditions: cardiac toxicity; unspecified childhood solid tumor, protocol specific
19.		No longer recruiting	Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma Condition: untreated childhood medulloblastoma
20.		No longer recruiting	Interferon Alfa in Treating Children With HIV-Related Cancer Conditions: Leukemia; Lymphoma
21.		No longer recruiting	Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia Conditions: childhood acute myeloid leukemia in remission; recurrent childhood acute myeloid leukemia; ...
22.		No longer recruiting	Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy Conditions: unspecified childhood solid tumor, protocol specific; Drug Toxicity
23.		No longer recruiting	Irofulven in Treating Children With Recurrent or Refractory Solid Tumors Condition: unspecified childhood solid tumor, protocol specific
24.		No longer recruiting	O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors Conditions: recurrent childhood brain stem glioma; childhood choroid plexus tumor; recurrent childhood visual pathway glioma; ...
25.		No longer recruiting	Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia Conditions: B-cell childhood acute lymphocytic leukemia; TdT positive childhood acute lymphocytic leukemia; recurrent childhood acute lymphocytic leukemia; ...
26.		No longer recruiting	Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma Condition: untreated childhood medulloblastoma
27.		Completed	Raltitrexed in Treating Children With Refractory Acute Leukemia Conditions: recurrent childhood acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia
28.		No longer recruiting	Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors Condition: unspecified childhood solid tumor, protocol specific
29.		Completed	Topotecan in Treating Children With Refractory Leukemia Conditions: recurrent childhood acute myeloid leukemia; refractory chronic myelogenous leukemia; recurrent childhood acute lymphocytic leukemia
30.		Completed	Vinblastine and Methotrexate in Treating Children With Desmoid Tumors Condition: desmoid tumor